Evidence map›Paper›PMID 30853710›Full record

ArticleJournal of human genetics2019

Investigation of novel variations of ORAI1 gene and their association with Kawasaki disease.

Kyaw Thiha, Yoichi Mashimo, Hiroyuki Suzuki, Hiromichi Hamada, Akira Hata, Toshiro Hara, Toshihiro Tanaka, Kaoru Ito, Yoshihiro Onouchi, Japan Kawasaki Disease Genome Consortium

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Combined Single Nucleotide Variants ofChildren (Basel, Switzerland) · 2021
    Article
  7. ORAI1 CaFrontiers in cell and developmental biology · 2021
    Review
  8. Article
  9. Article
  10. Immunogenetics of Kawasaki disease.Clinical reviews in allergy & immunology · 2020
    Review
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Kyaw ThihaDepartment of Public Health, Chiba University Graduate School of Medicine, Chiba, Chiba, Japan.
Yoichi MashimoDepartment of Public Health, Chiba University Graduate School of Medicine, Chiba, Chiba, Japan.
Hiroyuki SuzukiDepartment of Pediatrics, Wakayama Medical University, Wakayama, Wakayama, Japan.
Hiromichi HamadaDepartment of Pediatrics, Tokyo Women's Medical University, Yachiyo Medical Center, Yachiyo, Chiba, Japan.
Akira HataDepartment of Public Health, Chiba University Graduate School of Medicine, Chiba, Chiba, Japan.
Toshiro HaraFukuoka Children's Hospital and Medical Center for Infectious Diseases, Fukuoka, Japan.
Toshihiro TanakaDepartment of Human Genetics and Disease Diversity, Tokyo Medical and Dental University, Tokyo, Japan.ORCID http://orcid.org/0000-0001-6201-9784
Kaoru ItoLaboratory for Cardiovascular Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
Yoshihiro OnouchiDepartment of Public Health, Chiba University Graduate School of Medicine, Chiba, Chiba, Japan. onouchy@chiba-u.jp.
Japan Kawasaki Disease Genome Consortium
Chiba University · JPFukuoka Children's Hospital and Medical Center for Infectious Diseases · JPRIKEN Center for Integrative Medical Sciences · JPTokyo Medical and Dental University · JPTokyo Women's Medical University · JPWakayama Medical University · JP

Funding

Japan Agency for Medical Research and Development (AMED) JP17ek0410039Ministry of Education, Culture, Sports, Science and Technology (MEXT) 25293139Ministry of Health, Labour and Welfare (Ministry of Health, Labour and Welfare, Japan) 0401040
6 · The paper itself

Abstract

ORAI1 encodes a calcium channel essential in the store-operated calcium entry mechanism. A previous genetic association study identified a rare in-frame insertion variant of ORAI1 conferring Kawasaki disease (KD). To deepen our understanding of the involvement of rare variants of ORAI1 in KD pathogenesis, we investigated 3812 patients with KD and 2644 healthy individuals for variations in the protein-coding region of ORAI1. By re-sequencing the study participants' DNA, 27 variants with minor allele frequencies (MAFs) < 0.01 that had not been examined in the previous study were identified. Although no significant association with KD was observed either in single-variant analyses or in a collapsing method analysis of the 27 variants, stratification by MAFs, variant types, and predicted deleteriousness revealed that six rare, deleterious, missense variants (MAF < 0.001, CADD C-score ≥ 20) were exclusively present in KD patients, including three refractory cases (OR = ∞, P = 0.046). The six missense variants include p.Gly98Asp, which has been demonstrated to result in gain of function leading to constitutive Ca

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseCalciumChild, PreschoolFemaleGain of Function MutationGene FrequencyHumansInfantMaleMucocutaneous Lymph Node SyndromeMutation, MissenseORAI1 ProteinPolymorphism, Single NucleotideCalciumORAI1 ProteinORAI1 protein, human

Identifiers

PMID30853710
OpenAlexW2921330035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.